IGF-1 LR3 is a modified analogue of insulin-like growth factor 1 engineered with structural changes that alter its interaction with IGF-binding proteins and extend its activity in experimental systems.
$132.30$189.00 was, now $132.30
Form Vial
Selected: Vial · 1mg — $189.00
Bundle & Save
Checking documentation…
Research highlights
A modified insulin-like growth factor-1 analog with an extended amino-acid sequence designed to alter binding characteristics
Research interest: IGF-1 receptor signaling, cellular growth, glucose metabolism, protein synthesis, and growth-factor biology
This places it within endocrine and growth-factor research involving receptor activation, pituitary signaling, or downstream IGF-related pathways
These research areas can involve different models, endpoints, and analytical methods, so findings should be interpreted within the design and limitations of each study
For laboratory research use only. Not for human or veterinary use.